Advertisement

Diseases of Intermediary Metabolism

  • Reinhard L. Friede

Abstract

Several metabolic diseases of adulthood, particularly hepatic coma, hepatolenticular degeneration and uremia, produce a peculiar type of glial proliferation known as “metabolic astrocytosis”, or glia cells of Alzheimer type II. Metabolic astrocytosis as a consequence of acquired hepatic diseases has been defined mostly through the studies of Adams and Foley (1953) and Victor et al. (1965). It consists of an increase in the number and size of astrocytic nuclei which may appear in pairs or in clusters if proliferation is intense. The nuclei enlarge significantly and may reach nearly twice their normal size; they are distinctly vesicular with a prominent nuclear membrane encompassing a watery, empty-appearing nucleoplasm which may contain sparse chromatin particles resembling nucleoli (Fig. 154). Staining reactions for glycogen show usually single intranuclear inclusions in many of the nuclei, varying in size from small grains to larger than a nucleolus. The cytoplasmic bodies of the astrocytes are not discernible on light microscopic examination except for an occasional tuft of lightly stained cytoplasm; hence, the term “naked glial nuclei”. No fibrillary gliosis is seen in Holzer stains.

Keywords

White Matter Amino Acid Metabolism Urea Cycle Intermediary Metabolism Maple Syrup Urine Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams, R. D., Foley, J. M.: Neurological complications of liver disease. Ass. Res. nerv. Dis. Proc. 32: 198–237, 1953.Google Scholar
  2. Allan, J. D., Cusworth, D. C., Dent, C. E., Wilson, V. K.: A disease probably hereditary, characterized by severe mental deficiency and a constant gross abnormality of amino acid metabolism. Lancet 1: 182–187, 1958.PubMedCrossRefGoogle Scholar
  3. Alvord, E. C., Stevenson, L. D., Vogel, F. S., Engle, R. L.: Neuropathologic findings in phenyl-pyruvic oligophrenia (phenyl-ketonuria). J. Neuropath. exp. Neurol. 9: 298–310, 1950.PubMedCrossRefGoogle Scholar
  4. Anderson, J. M.: Spongy degeneration in the white matter of the central nervous system in the newborn: pathological findings in three infants, one with hyperglycinaemia. J. Neurol. Neurosurg. Psychiat. 32: 328–337, 1969.PubMedCrossRefGoogle Scholar
  5. Baumgartner, R., Scheidegger, S., Stadler, G., Hottinger, A.: Argininbernsteinsäure-Krankheit des Neugeborenen mit letalem Verlauf. Helv. paediat. Acta 23: 77–106, 1968.PubMedGoogle Scholar
  6. Berry, H., Sutherland, B., Guest, G. M.: Phenylalanine tolerance test on relatives of phenylketonuric children. Amer. J. hum. Genet. 9: 310–316, 1957.PubMedGoogle Scholar
  7. Blau, K., Summer, G. K., Newsome, H. C., Edwards, C. H., Mamer, O. A.: Phenylalanine loading and aromatic acid excretion in normal subjects and heterozygotes for phenylketonuria. Clin. chim. Acta 45: 197–205, 1973.PubMedCrossRefGoogle Scholar
  8. Bruton, C. J., Corsellis, J. A. N., Russell, A.: Hereditary hyper-ammonaemia. Brain 93: 423–434, 1970.PubMedCrossRefGoogle Scholar
  9. Carson, N. A., Neill, D. W.: Metabolic abnormalities detected in survey of mentally backward individuals in Northern Ireland. Arch. Dis. Child. 37: 505–513, 1962.PubMedCrossRefGoogle Scholar
  10. Cavanagh, J. B., Kyu, M. H.: Type II Alzheimer change experimentally produced in astrocytes in the rat. J. Neurol. Sci. 12: 63–75, 1971.PubMedCrossRefGoogle Scholar
  11. Childs, B., Nyham, W. L., Borden, M., Bard, L., Cooke, R. E.: Idiopathic hyperglycinemia and hyperglycinuria: a new disorder of amino acid metabolism. Pediatrics 27: 522–538, 1961.PubMedGoogle Scholar
  12. Chou, S.-M., Waisman, H. A.: Spongy degeneration of the central nervous system. Case of homocystinuria. Arch. Path. (Chic.) 79: 357–363, 1965.Google Scholar
  13. Cochrane, W. A., Collins-Williams, C., Donohue, W. L.: Superior hemorrhagic polioencephalitis (Wernicke’s disease) occurring in an infant. Pediatrics 28: 771–777, 1961.PubMedGoogle Scholar
  14. Cooper, J. R., Itokawa, Y., Pincus, J. H.: Thiamine triphosphate deficiency in necrotizing encephalomyelopathy. Science 164: 72–73, 1969.CrossRefGoogle Scholar
  15. Crome, L.: The association of phenylketonuria with leucodystrophy. J. Neurol. Neurosurg. Psychiat. 25: 149–153, 1962.PubMedCrossRefGoogle Scholar
  16. Crome, L., Dutton, G., Ross, C. F.: Maple syrup urine disease. J. Path. Bact. 81: 379–384, 1961.PubMedCrossRefGoogle Scholar
  17. Crome, L., Pare, C. M. B.: Phenylketonuria. J. ment. Sci. 106: 862–883, 1960.Google Scholar
  18. Crome, L., Tymms, V., Woolf, L. I.: A chemical investigation of the defects of myelination in phenylketonuria. J. Neurol. Neurosurg. Psychiat. 25: 143–148, 1962.PubMedCrossRefGoogle Scholar
  19. Cumings, J. N., Grundt, I. K., Yanagihara, T.: Lipid changes in the brain in phenylketonuria. J. Neurol. Neurosurg. Psychiat. 31: 334–337, 1968.PubMedCrossRefGoogle Scholar
  20. Davis, R. A., Wolf, A.: Infantile beriberi associated with Wernicke’s encephalopathy. Pediatrics 21: 409–420, 1958.PubMedGoogle Scholar
  21. Diezel, P. B., Martin, K.: Die Ahornsirupkrankheit mit familiärem Befall. Virchows Arch. path. Anat. 337: 425–445, 1964.Google Scholar
  22. Diezel, P. B., Martin, K.: Hyperglycinämie (Glycinose) mit familiärer idiopathischer Hyperglycinurie. Dtsch. med. Wschr. 91: 2249–2254, 1966.PubMedCrossRefGoogle Scholar
  23. Ebels, E. J.: Neuropathological observations in a patient with carbamylphosphatesynthetase deficiency and in two sibs. Arch. Dis. Child. 47: 47–51, 1972.PubMedCrossRefGoogle Scholar
  24. Efron, M. L.: Disorders of proline and hydroxyproline metabolism. In: The Metabolic Base of Inherited Disease (Stanbury, J. B., Wyngaarden, J. B., Fredrickson, D. S., eds.), Chapter 18. New York: McGraw-Hill 1966.Google Scholar
  25. Farkas-Bargeton, E., Goutières, F., Richardet, J. M., Thieffry, S., Brissaud, H. E.: Leucoencéphalopathie familiale associée à une acidose lactique congénitale. Acta neuropath. (Berl.) 17: 156–168, 1971.CrossRefGoogle Scholar
  26. Feigin, I., Wolf, A.: A disease in infants resembling chronic Wernicke’s encephalopathy. J. Pediat. 45: 243–263, 1954.PubMedCrossRefGoogle Scholar
  27. Fellman, J. H.: Epinephrine metabolites and pigmentation in the central nervous system in a case of phenylpyruvic oligophrenia. J. Neurol. Neurosurg. Psychiat. 21: 58–62, 1958.PubMedCrossRefGoogle Scholar
  28. Fölling, A.: Über Ausscheidung von Phenylbrenztraubensäure in den Harn als Stoffwechselanomalie in Verbindung mit Imbezillität. Hoppe Seyler Z. Physiol. Chem. 227: 169–176, 1934.CrossRefGoogle Scholar
  29. Gatfield, P. D., Taller, E., Hinton, G. G., Wallace, A. C., Abdelnour, G. M., Haust, M. D.: Hyperpipecolactemia: A new metabolic disorder associated with neuropathy and hepatomegaly. Canad. Med. Ass. J. 99: 1215–1233, 1968.PubMedGoogle Scholar
  30. Gerritsen, T., Vaughn, J. G., Waisman, H. A.: Identification of homocystine in urine. Biochem. biophys. Res. Commun. 9: 493–496, 1962.Google Scholar
  31. Gerstl, B., Malamud, N., Eng, L. F., Hayman, B. S.: Lipid alterations in human brains in phenylketonuria. Neurology (Minneap.) 17: 51–57, 1967.CrossRefGoogle Scholar
  32. Greenhouse, A. H., Schneck, S. A.: Subacute necrotizing encephalomyelopathy. A reappraisal of the thiamine deficiency hypothesis. Neurology (Minneap.) 18: 1–9, 1968.CrossRefGoogle Scholar
  33. Grover, W. D., Auerbach, V. H., Patel, M. S.: Biochemical studies and therapy in subacute necrotizing encephalomyelopathy (Leigh’s syndrome). J. Pediat. 81: 39–44, 1972.PubMedCrossRefGoogle Scholar
  34. Hartmann, A. F., Wohltman, H. J., Pukerson, M. L., Wesley, M. E.: Lactate metabolism: Studies of a child with a serious congenital deviation. J. Pediat. 61: 165–180, 1962.PubMedCrossRefGoogle Scholar
  35. Hommes, F. A., de Groot, C. J., Wilmink, C. W., Jonxis, J. H. P.: Carbamylphosphate synthetase deficiency in an infant with severe cerebral damage. Arch. Dis. Child. 44: 688–693, 1969.PubMedCrossRefGoogle Scholar
  36. Hommes, F. A., Polman, H. A., Reerink, J. D.: Leigh’s encephalomyelopathy: an inborn error of gluconeogenesis. Arch. Dis. Child. 43: 423–426, 1968.PubMedCrossRefGoogle Scholar
  37. Hopkins, I. J., Connelly, J. F., Dawson, A. G., Hird, F. J. R., Maddison, T. G.: Hyperammonemia due to ornithine transcarbamylase deficiency. Arch. Dis. Child. 44: 143–148, 1969.PubMedCrossRefGoogle Scholar
  38. Hsia, D. Y., Driscoll, K. W., Troll, W., Knox, W. E.: Detection by phenylalanine tolerance tests of heterozygous carriers of phenyl ketonuria. Nature 178: 1239–1240, 1956.PubMedCrossRefGoogle Scholar
  39. Irreverre, F., Mudd, S. H., Heizer, W. D., Laster, L.: Sulfite oxidase deficiency: Studies of a patient with mental retardation, dislocated ocular lenses, and abnormal urinary excretion of S-sulfa-L-cysteine, sulfite and thiosulfate. Biochem. Med. 1: 187–217, 1967.CrossRefGoogle Scholar
  40. Jellinger, K., Seitelberger, F.: Subacute necrotizing encephalomyelopathy (Leigh). Erg. inn, Med. Kinderhkd. 29: 155–219, 1970.CrossRefGoogle Scholar
  41. Jervis, G. A.: Phenylpyruvic oligophrenia. Arch. Neurol. Psychiat. (Chic.) 38: 944–963, 1937.Google Scholar
  42. Jervis, G. A.: Phenylpyruvic oligophrenia: deficiency of Phenylalanine oxydising System. Proc. Soc. exp. Biol. Med. 82: 514–515, 1953.PubMedGoogle Scholar
  43. Kamoshita, S., Aguilar, M. J., Landing, B. H.: Infantile subacute necrotizing encephalomyelopathy. Amer. J. Dis. Child. 116: 120–129, 1968.PubMedGoogle Scholar
  44. Knox, W. E.: Phenylketonuria. In: The Metabolic Basis of Inherited Disease (Stanbury, J. B., Wyngaarden, J. B., Fredrickson, D. S., eds.), pp. 266–295, Chapter 11. New York: Blackiston, McGraw-Hill 1972.Google Scholar
  45. La Du, B. N., Gjessing, L. R.: Tyrosinosis and tyrosinemia. In: The Metabolie Base of Inherited Disease (Stanbury, J. B., Wyngaarden, J. B., Fredrickson, D. S., eds.), Chapter 12, pp. 296–307. New York: McGraw-Hill 1966.Google Scholar
  46. Leigh, D.: Subacute necrotizing encephalomyelopathy in an infant. J. Neurol. Neurosurg. Psychiat. 14: 216–221, 1951.PubMedCrossRefGoogle Scholar
  47. Levin, B., Abraham, J. M., Oberholzer, V. G., Burges, E. A.: Hyperammonaemia: a deficiency of liver Ornithine transcarbamylase. Arch. Dis. Child. 44: 152–161, 1969.PubMedCrossRefGoogle Scholar
  48. Lewis, A. J.: Infantile subacute necrotizing encephalopathy. Canad. med. Ass. J. 93: 878–881, 1965.PubMedGoogle Scholar
  49. Lewis, P. D., Miller, A. L.: Arginosuccinic aciduria. Brain 93: 413–422, 1970.PubMedCrossRefGoogle Scholar
  50. Malmud, N.: Neuropathology of phenylketonuria. J. Neuropath. exp. Neurol. 25: 254–268, 1966.CrossRefGoogle Scholar
  51. Martin, J.-J., Schlote, W.: Central nervous System lésions in disorders of amino-acid metabolism. A neuropathological study. J. Neurol. Sci. 15: 49–76, 1972.PubMedCrossRefGoogle Scholar
  52. Menkes, J. H., Hurst, P. L., Craig, J. M.: New syndrome: Progressive familial infantile cerebral dysfunction associated with an unusual urinary substance. Pediatrics 14: 462–467, 1954.PubMedGoogle Scholar
  53. Menkes, J. H., Philippart, M., Fiol, R. E.: Cerebral lipids in maple syrup disease. J. Pediat. 66: 584–594, 1965.PubMedCrossRefGoogle Scholar
  54. Menkes, J. H., Solcher, H.: Maple syrup disease. Effects of dietary therapy on cerebral lipids. Arch. Neurol. (Chic.) 16: 486–491, 1967.CrossRefGoogle Scholar
  55. Montpetit, V. J. A., Andermann, F., Carpenter, S., et al.: Subacute necrotizing encephalomyelopathy. A review and study of two families. Brain 94: 1–30, 1971.PubMedCrossRefGoogle Scholar
  56. Mudd, S. H., Finkelstein, J. D., Irreverre, F., Laster, L.: Homocystinuria: an enzymatic defect. Science 143: 1443–1445, 1964.PubMedCrossRefGoogle Scholar
  57. Namiki, H.: Subacute necrotizing encephalomyelopathy. Case report with special emphasis on associated pathology of peripheral nervous system. Arch. Neurol. (Chic.) 12: 98–107, 1965.CrossRefGoogle Scholar
  58. Paine, R. S.: The variability in manifestations of untreated patients with phenylketonuria. Pediatrics 20: 290–302, 1957.PubMedGoogle Scholar
  59. Perry, T. L., Hardwick, D. F., Dixon, G. H., Dolman, C. L., Hansen, S.: Hypermethionemia: a metabolic disorder associated with cirrhosis, islet cell hyperplasia, and renal tubular degeneration. Pediatrics 36: 236–250, 1965.PubMedGoogle Scholar
  60. Pincus, J. H., Itokawa, Y., Cooper, J. R.: Enzyme-inhibiting factor in subacute necrotizing encephalopathy. Neurology (Minneap.) 19: 841–845, 1969.CrossRefGoogle Scholar
  61. Prensky, A. L., Carr, S., Moser, H. W.: Development of myelin in inherited disorders of amino acid metabolism. Arch. Neurol. (Chic.) 19: 552–558, 1968.CrossRefGoogle Scholar
  62. Reye, R. D. K.: Subacute necrotizing encephalomyelopathy. J. Path. Bact. 79: 165–173, 1960.CrossRefGoogle Scholar
  63. Rosenblum, W. I.: Neuropathologic changes in a case of sulfite oxidase deficiency. Neurology (Minneap.) 18: 1187–1196, 1968.CrossRefGoogle Scholar
  64. Rushton, D. I.: Spongy degeneration of the white matter of the central nervous system associated with hyperglycinuria. J. clin. Path. 21: 456–462, 1968.PubMedCrossRefGoogle Scholar
  65. Scriver, C. R., Efron, M. L.: Disorders of proline and hydroxyproline metabolism. In: The Metabolic Basis of Inherited Disease (Stanbury, J. B., Wyngaarden, J. B., Fredrickson, D. S., eds.), Chapter 16, pp. 351–369. New York: McGraw-Hill 1972.Google Scholar
  66. Shah, S. N., Peterson, N. A., McKean, C. M.: Lipid composition of human cerebral white matter and myelin in phenylketonuria. J. Neurochem. 19: 2369–2376, 1972.PubMedCrossRefGoogle Scholar
  67. Silberberg, D. H.: Phenylketonuria metabolites in cerebellum culture morphology. Arch. Neurol. (Chic.) 17: 524–529, 1967.CrossRefGoogle Scholar
  68. Silberman, J., Dancis, J., Feigin, I.: Neuropathological observations in maple syrup urine disease. Arch. Neurol. (Chic.) 5: 351–363, 1961.CrossRefGoogle Scholar
  69. Sipe, J. C.: Leigh’s syndrome: The adult form of subacute necrotizing encephalomyelopathy with predilection for the brainstem. Neurology (Minneap.) 23: 1030–1038, 1973.CrossRefGoogle Scholar
  70. Smith, A. J., Strang, L. B.: An inborn error of metabolism with the urinary excretion of α-hydroxy-butyric acid and phenylpyruvic acid. Arch. Dis. Child. 33: 109–113, 1958.PubMedCrossRefGoogle Scholar
  71. Solitare, G. B., Shih, V. E., Nelligan, D. J., Dolan, T. F., Jr.: Arginosuccinic aciduria: clinical, biochemical, anatomical, and neuropathological observations. J. ment. Defic. Res. 13: 153–170, 1969.PubMedGoogle Scholar
  72. Stevenson, R. E., Huntley, C. C.: Congenital malformations in offspring of phenylketonuric mothers. Pediatrics 40: 33–45, 1967.PubMedGoogle Scholar
  73. Tanaka, T.: So-called breast milk intoxication. Amer. J. Dis. Child. 47: 1286–1298, 1934.Google Scholar
  74. Tom, M. I., Rewcastle, N. B.: Infantile subacute necrotizing encephalopathy. Neurology (Minneap.) 12: 624–628, 1962.CrossRefGoogle Scholar
  75. Udenfriend, S., Bessman, S. P.: The hydroxylation of phenylalanine and antipyrine in phenylpyruvic oligophrenia. J. Biol. Chem. 203: 961–966, 1953.PubMedGoogle Scholar
  76. Verhaart, W. J. C.: Symmetrical degeneration of neostriatum in Chinese infants. Arch. Dis. Child. 13: 225–234, 1938.PubMedCrossRefGoogle Scholar
  77. Victor, M., Adams, R. D., Cole, M.: The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration. Medicine 44: 345–396, 1965.PubMedCrossRefGoogle Scholar
  78. White, H. H., Rowland, L. P., Araki, S., Thompson, H. L., Cowen, D.: Homocystinuria. Arch. Neurol. (Chic.) 13: 455–470, 1965.CrossRefGoogle Scholar
  79. Woody, N. C., Snyder, C., Harris, J. A.: Hyperprolinemia: Clinical and biochemical family study. Pediatrics 44: 554–563, 1969.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 1975

Authors and Affiliations

  • Reinhard L. Friede
    • 1
    • 2
  1. 1.Case Western Reserve UniversityClevelandUSA
  2. 2.University of ZurichSwitzerland

Personalised recommendations